The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
–
Children who live in “low-opportunity” neighborhoods are up to 20 times more likely to be shot than those living in “high-opportunity” areas, according to a new study led by Northwestern University researchers.
Dr. Anne Stey, a senior study author and Northwestern Medicine trauma surgeon, said their findings show the fewer opportunities a child has in their neighborhood, the higher the odds of them ending up in the hospital with a gun injury.
–
The Food and Drug Administration sent warning letters this month to five companies that sell sunscreen mousses and foams. The agency wrote a message on X to “beware” of these novel products, stating they may not be effective. The F.D.A. allows companies to market sunscreens in a number of forms — including sticks, sprays, powders, oils, gels, ointments, even butters — but not foams or mousses, which have gone viral for their whipped-cream-like consistency.
“The F.D.A. has a very tight definition of what they allow to be marketed as sunscreens,” said Dr. Ahmad Amin, a dermatologist at Northwestern Medicine.
–
“What it is is basically not having to intubate or put somebody under general anesthesia for a kidney transplant, which is pretty remarkable, given that we’re the only place in the country that’s doing this,” said Satish Nadig, MD, PhD, Edward G. Elcock Professor of Surgical Research at Northwestern University Feinberg School of Medicine.
–
“Significant data demonstrate that mRNA vaccines are safe and highly effective at preventing severe disease, hospitalization and death due to COVID-19,” Tina Tan, who is also a Lurie Children’s Hospital physician and faculty member at Northwestern University’s Feinberg School of Medicine, said in the statement. “MRNA technology also shows potential against other respiratory pathogens like influenza and is worthy of further study.”
–
Scientists at Northwestern University have discovered a drug that could offer a new approach to treating life-threatening food allergies. The drug Zileuton, a pill that has already been approved by the Food and Drug Administration, is used for asthma.
Dr. Stephanie Eisenbarth and Dr. Adam Williams, co-senior study authors who work in allergy and immunology at the Feinberg School of Medicine, conducted a study on mice that showed the drug could lead to new protection for millions of people living with food allergies.
–
For that reason, melatonin supplements are most helpful for people with sleep timing problems, said Phyllis C. Zee, the medical director of the Center for Circadian and Sleep Medicine at the Northwestern University Feinberg School of Medicine. That includes people with jet lag, shift workers who work late at night or early in the morning, and people who routinely struggle to fall asleep until it’s extremely late at night.
–
Super-agers are a diverse bunch; they don’t share a magic diet, exercise regimen or medication. But the one thing that does unite them is “how they view the importance of social relationships,” said Sandra Weintraub, a professor of psychiatry and behavioral sciences at the Northwestern Feinberg School of Medicine, who has been involved in the research since the start. “And personality wise, they tend to be on the extroverted side.”
–
Dr. M. Marsel Mesulam, who founded the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at the Northwestern University Feinberg School of Medicine in the late 1990s, first defined a SuperAger. Mesulam Center researchers reflected on a quarter-century of SuperAger study in an analysis published Thursday in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
–
While anaphylaxis is currently primarily treated with epinephrine (adrenaline), it’s hoped the asthma drug called Zileuton could offer a simple pill that temporarily shields allergic individuals by blocking the body’s anaphylactic pathway before it activates.
“It was actually shocking how well Zileuton worked,” said Dr. Stephanie Eisenbarth, study author and Allergy and Immunology chief at Northwestern’s Feinberg School of Medicine, in a statement.
–
Nearly four months have passed since the Donald Trump administration abruptly froze $790 million in federal funding at Northwestern University, and the school’s fragile research infrastructure has been pummeled by cuts.
Portions of research and clinical trials have ground to a halt. Labs have been instructed to scrutinize every expense, from equipment to personnel.